Phase II study of a fixed dose-rate infusion of gemcitabine associated with docetaxel in advanced non-small-cell lung carcinoma

To evaluate the efficacy and toxicity profile of the combination of docetaxel and prolonged gemcitabine infusion in front-line chemonaive patients with advanced non-small-cell lung cancer (NSCLC). A total of 50 chemonaive patients diagnosed with advanced NSCLC according to the AJCC/TNM classificatio...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer chemotherapy and pharmacology 2005-02, Vol.55 (2), p.197-202
Hauptverfasser:	DE CASTRO, J, LORENZO, A, GONZALEZ BARON, M, MORALES, S, BELON, J, DORTA, J, LIZON, J, MADRONAL, C, GALLURT, P. M, CASADO, E, FELIU, J
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antineoplastic agents Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biological and medical sciences Carcinoma, Non-Small-Cell Lung - drug therapy Deoxycytidine - administration & dosage Deoxycytidine - adverse effects Deoxycytidine - analogs & derivatives Female Humans Lung Neoplasms - drug therapy Male Medical sciences Middle Aged Pharmacology. Drug treatments Pneumology Taxoids - administration & dosage Taxoids - adverse effects Tumors of the respiratory system and mediastinum
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!